Osivax
Last updated: May 01, 2024
Alexandre Levert - Founder and CEO
Country: France | Funding: $59.2M (+)
Website: http://www.osivax.com/
Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies.
Website: http://www.osivax.com/
Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies.